ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | +42.9% | 93,841 | +63.8% | 0.00% | – |
| Q2 2022 | $14,000 | -17.6% | 57,292 | -2.2% | 0.00% | – |
| Q1 2022 | $17,000 | -37.0% | 58,588 | +18.7% | 0.00% | – |
| Q4 2021 | $27,000 | -81.0% | 49,354 | -64.8% | 0.00% | – |
| Q3 2021 | $142,000 | -91.4% | 140,324 | -88.2% | 0.00% | – |
| Q2 2021 | $1,644,000 | -61.9% | 1,190,997 | -53.0% | 0.00% | -100.0% |
| Q1 2021 | $4,311,000 | +83.4% | 2,535,688 | +33.7% | 0.00% | – |
| Q4 2020 | $2,351,000 | +106.6% | 1,896,883 | +136.7% | 0.00% | – |
| Q3 2020 | $1,138,000 | +53.2% | 801,424 | +30.4% | 0.00% | – |
| Q2 2020 | $743,000 | +108.7% | 614,431 | +103.2% | 0.00% | – |
| Q1 2020 | $356,000 | -81.8% | 302,308 | -67.3% | 0.00% | – |
| Q4 2019 | $1,952,000 | +167.8% | 924,941 | +179.3% | 0.00% | – |
| Q3 2019 | $729,000 | +701.1% | 331,153 | +823.4% | 0.00% | – |
| Q2 2019 | $91,000 | -73.8% | 35,862 | -64.0% | 0.00% | – |
| Q1 2019 | $347,000 | -23.9% | 99,687 | -49.5% | 0.00% | – |
| Q4 2018 | $456,000 | +179.8% | 197,521 | +364.5% | 0.00% | – |
| Q3 2018 | $163,000 | +61.4% | 42,521 | +42.0% | 0.00% | – |
| Q2 2018 | $101,000 | +124.4% | 29,942 | +41.2% | 0.00% | – |
| Q1 2018 | $45,000 | +28.6% | 21,199 | +20.9% | 0.00% | – |
| Q4 2017 | $35,000 | -73.1% | 17,537 | -37.9% | 0.00% | – |
| Q3 2017 | $130,000 | -27.8% | 28,255 | -66.2% | 0.00% | – |
| Q2 2017 | $180,000 | -55.9% | 83,656 | -35.5% | 0.00% | – |
| Q1 2017 | $408,000 | -34.2% | 129,736 | -45.6% | 0.00% | – |
| Q4 2016 | $620,000 | +581.3% | 238,498 | +922.7% | 0.00% | – |
| Q3 2016 | $91,000 | +59.6% | 23,321 | +9.3% | 0.00% | – |
| Q2 2016 | $57,000 | -62.0% | 21,337 | -56.2% | 0.00% | – |
| Q1 2016 | $150,000 | -72.7% | 48,702 | -65.8% | 0.00% | – |
| Q4 2015 | $549,000 | -37.5% | 142,522 | -50.5% | 0.00% | – |
| Q3 2015 | $878,000 | -39.5% | 287,660 | -16.0% | 0.00% | -100.0% |
| Q2 2015 | $1,452,000 | -37.8% | 342,436 | -43.3% | 0.00% | 0.0% |
| Q1 2015 | $2,333,000 | -64.4% | 604,249 | -38.0% | 0.00% | -50.0% |
| Q4 2014 | $6,554,000 | +313.8% | 973,857 | +237.6% | 0.00% | +100.0% |
| Q3 2014 | $1,584,000 | +178.9% | 288,478 | +420.7% | 0.00% | – |
| Q2 2014 | $568,000 | +67.6% | 55,404 | +96.0% | 0.00% | – |
| Q1 2014 | $339,000 | +52.0% | 28,263 | +43.3% | 0.00% | – |
| Q4 2013 | $223,000 | -21.2% | 19,722 | -24.6% | 0.00% | – |
| Q3 2013 | $283,000 | +64.5% | 26,144 | +40.9% | 0.00% | – |
| Q2 2013 | $172,000 | – | 18,559 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $21,040,000 | 1.36% |
| Palo Alto Investors LP | 1,634,608 | $6,359,000 | 0.37% |
| WealthTrust Axiom LLC | 200,000 | $778,000 | 0.29% |
| Granahan Investment Management | 1,455,676 | $5,663,000 | 0.18% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $497,000 | 0.10% |
| Joel Isaacson & Co., LLC | 80,660 | $314,000 | 0.06% |
| Cornerstone Capital, Inc. | 39,700 | $154,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $1,096,000 | 0.02% |
| Advisor Group, Inc. | 131,992 | $513,000 | 0.01% |
| INTEGRATED WEALTH COUNSEL, LLC | 1,000 | $4,000 | 0.01% |